Canine Prostatitis: Diagnosis and Medical Management

Prostatitis is one of the most clinically significant prostatic disorders encountered in mature male dogs. While acute cases often present with obvious systemic illness, chronic prostatitis can remain clinically silent, making timely diagnosis challenging. The condition frequently develops secondary to underlying prostatic abnormalities such as benign prostatic hyperplasia (BPH) or prostatic cysts, although ascending bacterial infection through the urethra remains the most common route of infection. Hematogenous spread and extension from cystitis may also occur¹. Recognizing the diverse clinical presentations and selecting an appropriate diagnostic and treatment strategy are essential for achieving a favorable clinical outcome. 

Recognizing Acute and Chronic Prostatitis 

Acute prostatitis commonly presents as a systemic illness. Affected dogs may exhibit anorexia, fever, depression, pain on rectal palpation of the prostate, dysuria, tenesmus, haematuria, pollakiuria, oedema involving the scrotum, prepuce or hindlimbs, and a characteristic stiff-legged gait. In severe cases associated with prostatic abscessation, peritonitis or septicemia, signs of septic shock may also develop^1,2. 

In contrast, chronic prostatitis may present with few or no obvious clinical signs. Reduced fertility, poor semen quality characterized by decreased sperm motility or abnormal morphology, and occasionally reduced libido due to painful prostatic contractions may be the only clinical indicators^1,2. This subtle presentation highlights the importance of maintaining a high index of suspicion, particularly in intact older male dogs with recurrent urinary tract infections or unexplained reproductive problems. 

Common Bacterial Causes 

The prostate possesses several natural defense mechanisms; however, these can become compromised when concurrent BPH or prostatic cysts are present. Escherichia coli is the organism most frequently isolated from canine prostatitis. Other commonly encountered bacteria include Mycoplasma, Staphylococcus, Streptococcus, Klebsiella, Proteus mirabilis, Pseudomonas, and Brucella canis. Fungal infections such as blastomycosis and cryptococcosis are reported only rarely¹. 

Establishing the Diagnosis 

Successful management begins with a systematic diagnostic approach. History, physical examination, transrectal palpation, diagnostic imaging, hematology, urinalysis, prostatic fluid evaluation, and bacterial culture all contribute to confirming the diagnosis. 

On rectal examination, the prostate is typically normal to slightly enlarged but markedly painful. Ultrasonography may reveal a diffuse increase in prostatic echogenicity that becomes progressively more prominent, while abdominal radiographs occasionally demonstrate prostatomegaly or mineralization. Urinalysis frequently identifies pyuria, bacteriuria, or haematuria. Whenever possible, urine should be collected by cystocentesis to improve interpretation of culture results¹. 

Evaluation of prostatic fluid is particularly valuable. Cytology commonly demonstrates numerous neutrophils containing ingested bacteria, together with evidence of suppurative inflammation. Culture of prostatic fluid yields growth of a single organism in more than 70% of affected dogs, allowing antimicrobial therapy to be directed by culture and sensitivity findings¹. 

Medical Management 

Effective treatment requires prolonged administration of antibiotics selected on the basis of culture and sensitivity. Drug selection should also consider pharmacokinetic characteristics that influence penetration into prostatic tissue. Because differences in pH between blood and prostatic fluid, together with lipid solubility and protein binding, affect drug distribution, not all antimicrobials achieve therapeutic concentrations within the prostate. 

More basic antibiotics such as trimethoprim and erythromycin penetrate the blood–prostate barrier more readily than acidic drugs. Fluoroquinolones also enter the prostate effectively regardless of pH, while highly lipid-soluble drugs including trimethoprim-sulfa, chloramphenicol and fluoroquinolones penetrate the prostatic acini more efficiently than poorly lipid-soluble agents¹. 

Treatment should continue for at least 4–6 weeks, followed by repeat cultures of both urine and prostatic fluid approximately 30 days after completion of therapy to confirm elimination of infection¹. 

Castration is recommended as an adjunct to medical management because bacterial infection is controlled more rapidly in castrated dogs than in intact males¹. 

Practical Clinical Insight 

• Consider prostatitis as a differential diagnosis in intact mature male dogs presenting with systemic illness, recurrent urinary tract infections, infertility, or unexplained haematuria. 

• Chronic prostatitis may be clinically silent, making reproductive abnormalities and recurrent lower urinary tract disease important diagnostic clues. 

• Whenever feasible, obtain urine by cystocentesis before initiating antimicrobial therapy to improve culture accuracy. 

• Culture and sensitivity testing of prostatic fluid provides valuable guidance for antibiotic selection and helps optimize long-term treatment success. 

• Re-evaluating the patient after completion of therapy is essential to confirm resolution of infection rather than relying solely on improvement in clinical signs. 

References 

1. Verma A, Singh R, Jawre S, Khan A, Namdev N, Vishvakarma S, Sinha A. Prostate disorders in dogs, with a focus on benign prostatic hyperplasia (BPH): An overview. International Journal of Veterinary Sciences and Animal Husbandry. 2024;9(1):868-75. https://www.researchgate.net/profile/Asad-Khan-160/publication/383217672 

2. Smith J. Canine prostatic disease: a review of anatomy, pathology, diagnosis, and treatment. Theriogenology. 2008 Aug 1;70(3):375-83. https://doi.org/10.1016/j.theriogenology.2008.04.039